| CAIXABANK BOLSA ESPAÑA 150, FI ESTANDAR | RV ESPAÑA | 65,00% | 200,67% | 254,10% | 351,53% |
| PICTET - CLEAN ENERGY TRANSITION I DY EUR | RVI ENERGÍA | 64,99% | 79,97% | 93,27% | 326,81% |
| PICTET - CLEAN ENERGY TRANSITION I EUR | RVI ENERGÍA | 64,99% | 79,98% | 93,26% | 327,44% |
| SCHRODER ISF ASIAN OPPORTUNITIES I ACC USD | RVI ASIA EX-JAPÓN | 64,96% | 83,31% | 56,11% | 238,95% |
| ALLIANZ HIGH DIVIDEND ASIA PACIFIC EQUITY I (H-EUR) EUR | RVI ASIA EX-JAPÓN VALOR | 64,91% | 95,47% | 59,53% | 102,85% |
| POLAR CAPITAL SMART MOBILITY I EUR CAP | RVI TECNOLOGÍA | 64,91% | 47,97% | · | · |
| UBS (LUX) EQUITY FUND - BIOTECH (USD) QL-ACC | RVI BIOTECNOLOGÍA | 64,85% | 52,73% | 37,61% | · |
| PICTET - CLEAN ENERGY TRANSITION I DY GBP | RVI ENERGÍA | 64,84% | 79,75% | 93,34% | · |
| TEMPLETON ASIAN GROWTH A (ACC) EUR | RVI ASIA EX-JAPÓN CRECIMIENTO | 64,81% | 82,66% | 39,80% | 136,37% |
| TEMPLETON ASIAN GROWTH A (YDIS) EUR | RVI ASIA EX-JAPÓN CRECIMIENTO | 64,80% | 82,70% | 39,80% | 133,59% |
| GOLDMAN SACHS ASIA EQUITY INCOME P CAP EUR | RVI ASIA EX-JAPÓN | 64,79% | 108,71% | 55,85% | 153,17% |
| TEMPLETON ASIAN GROWTH A (ACC) SGD | RVI ASIA EX-JAPÓN CRECIMIENTO | 64,79% | 82,80% | 40,34% | 136,69% |
| SCHRODER ISF GLOBAL EMERGING MARKET OPPORTUNITIES IZ ACC USD | RVI EMERGENTES | 64,76% | 84,12% | 56,35% | · |
| AMUNDI FUNDS EMERGING MARKETS EQUITY FOCUS EX CHINA A USD (C) | RVI EMERGENTES | 64,71% | · | · | · |
| JANUS HENDERSON HF - SUSTAINABLE FUTURE TECHNOLOGIES H2 EUR HEDGED | RVI TECNOLOGÍA | 64,68% | 122,26% | · | · |
| UBS (LUX) KEY SELECTION SICAV - ASIAN EQUITIES (USD) U-X-ACC | RVI ASIA EX-JAPÓN | 64,62% | 100,51% | 54,55% | 260,41% |
| BNP PARIBAS JAPAN SMALL CAP PRIVILEGE H EUR CAP | RVI JAPÓN SMALL/MID CAP | 64,54% | 143,01% | 174,54% | 388,51% |
| FRANKLIN GOLD AND PRECIOUS METALS I (ACC) USD | RVI MATERIAS PRIMAS | 64,54% | 201,71% | 162,07% | 216,83% |
| TEMPLETON ASIAN GROWTH A (ACC) HKD | RVI ASIA EX-JAPÓN CRECIMIENTO | 64,53% | 82,43% | 40,58% | 136,88% |
| UBS (LUX) EQUITY FUND - BIOTECH (USD) Q-ACC | RVI BIOTECNOLOGÍA | 64,53% | 51,82% | 36,24% | 148,79% |
